Smith Carey A.
Parsons Corporation ยท President & CEO
Smith Carey A. is listed in public filings as director, officer: President & CEO. This Smith Carey A. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Parsons Corporation (PSN), and Edison International (EIX). Investors use Smith Carey A.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $29M574.9k shares | BuyMay 8, 2026 | $599.3K12k shares | $49.94 | -- | |
| $29M575.4k shares | BuyMay 8, 2026 | $25.4K500 shares | $50.73 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --6.6k shares | Grant / ExerciseApr 23, 2026 | Disclosure amount unavailable2.7k shares | -- | -- | |
| $35M562.9k shares | Grant / ExerciseMar 9, 2026 | $655.1K10.5k shares | $62.55 | -- | |
| $38M573.4k shares | Grant / ExerciseFeb 26, 2026 | $472.9K7.1k shares | $66.31 | -- | |
| $38M580.5k shares | Grant / ExerciseFeb 20, 2026 | $4.4M67.8k shares | $65.53 | -- | |
| --453.1k shares | Grant / ExerciseFeb 20, 2026 | Disclosure amount unavailable59.8k shares | -- | -- | |
| --498k shares | Grant / ExerciseFeb 20, 2026 | Disclosure amount unavailable44.9k shares | -- | -- | |
| --648.2k shares | Grant / ExerciseFeb 20, 2026 | Disclosure amount unavailable150.2k shares | -- | -- | |
| $231k3.9k shares | OtherJan 1, 2026 | $591 shares | $60.02 | -- | |
| --3.9k shares | Grant / ExerciseJan 1, 2026 | Disclosure amount unavailable950 shares | -- | -- | |
| $24M393k shares | Grant / ExerciseDec 17, 2025 | $454.0K7.5k shares | $60.20 | -- | |
| --14.6k shares | Grant / ExerciseApr 24, 2025 | Disclosure amount unavailable3.1k shares | -- | -- | |
| $24M400.5k shares | Grant / ExerciseMar 9, 2025 | $315.5K5.2k shares | $60.17 | -- | |
| $21M371k shares | Grant / ExerciseMar 3, 2025 | $3.0M54.9k shares | $55.35 | -- | |
| --405.8k shares | Grant / ExerciseMar 3, 2025 | Disclosure amount unavailable34.8k shares | -- | -- | |
| --425.9k shares | Grant / ExerciseMar 3, 2025 | Disclosure amount unavailable121.8k shares | -- | -- | |
| $18M304.1k shares | Grant / ExerciseMar 1, 2025 | $455.0K7.8k shares | $58.22 | -- | |
| $18M311.6k shares | Grant / ExerciseFeb 26, 2025 | $421.9K7.1k shares | $59.08 | -- | |
| $232k2.9k shares | OtherJan 1, 2025 | $871 shares | $79.84 | -- | |
| --2.9k shares | Grant / ExerciseJan 1, 2025 | Disclosure amount unavailable350 shares | -- | -- | |
| $31M318.8k shares | Grant / ExerciseDec 17, 2024 | $726.4K7.5k shares | $96.33 | -- | |
| $27M328.2k shares | Grant / ExerciseJun 30, 2024 | $288.8K3.5k shares | $81.81 | -- |